A detailed history of Sentinus, LLC transactions in Clear Point Neuro, Inc. stock. As of the latest transaction made, Sentinus, LLC holds 14,970 shares of CLPT stock, worth $80,688. This represents 0.04% of its overall portfolio holdings.

Number of Shares
14,970
Previous 201,590 92.57%
Holding current value
$80,688
Previous $1.46 Million 93.08%
% of portfolio
0.04%
Previous 0.47%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

SELL
$6.03 - $7.86 $1.13 Million - $1.47 Million
-186,620 Reduced 92.57%
14,970 $101,000
Q2 2023

Aug 14, 2023

BUY
$6.54 - $10.58 $327,327 - $529,529
50,050 Added 33.03%
201,590 $1.46 Million
Q1 2023

May 15, 2023

BUY
$7.33 - $10.63 $401,610 - $582,417
54,790 Added 56.63%
151,540 $1.28 Million
Q4 2022

Feb 15, 2023

BUY
$7.7 - $11.21 $475,090 - $691,657
61,700 Added 176.03%
96,750 $819,000
Q3 2022

Nov 16, 2022

BUY
$9.82 - $16.49 $344,191 - $577,974
35,050 New
35,050 $363,000

Others Institutions Holding CLPT

About ClearPoint Neuro, Inc.


  • Ticker CLPT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 24,488,300
  • Market Cap $132M
  • Description
  • ClearPoint Neuro, Inc. operates as a medical device company primarily in the United States. The company develops and commercializes platforms for performing minimally invasive surgical procedures in the brain under direct, and intra-procedural magnetic resonance imaging (MRI) guidance. It offers ClearPoint system for the insertion of deep brain ...
More about CLPT
Track This Portfolio

Track Sentinus, LLC Portfolio

Follow Sentinus, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sentinus, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sentinus, LLC with notifications on news.